Form4insider filings, from the source

SEC Form 4 · accession 0001140361-15-045045

BIOLASE, INC · BIOL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Period of report
Nov 24, 2015
Accepted (ET)
Dec 18, 2015 · 11:30 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000811240

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2,F1Nov 24, 2015P100$0.92A5,885,703IBy Trust
Common StockF2,F1Nov 25, 2015P44,200$0.90A5,929,903IBy Trust
Common StockF2,F1Nov 26, 2015P2,045$0.89A5,931,948IBy Trust
Common StockF2,F1Nov 30, 2015P16,752$0.90A5,948,700IBy Trust
Common StockF2,F1Dec 2, 2015P5,900$0.85A5,954,600IBy Trust
Common StockF2,F1Dec 3, 2015P16,427$0.81A5,971,027IBy Trust
Common StockF2,F1Dec 4, 2015P5,286$0.81A5,976,313IBy Trust
Common StockF2,F1Dec 7, 2015P8,561$0.80A5,984,874IBy Trust
Common StockF2,F1Dec 8, 2015P14,596$0.79A5,999,470IBy Trust
Common StockF2,F1Dec 9, 2015P5,704$0.79A6,005,174IBy Trust
Common StockF2,F1Dec 10, 2015P31,699$0.78A6,036,873IBy Trust
Common StockF2,F1Dec 11, 2015P7,078$0.77A6,043,951IBy Trust
Common StockF2,F1Dec 14, 2015P42,923$0.74A6,086,874IBy Trust
Common StockF2,F1Dec 15, 2015P28,000$0.72A6,114,874IBy Trust
Common Stockholding———14,800IBy spouse

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses